Mediclinic International PLC Holding(s) in Company (9772Q)
December 05 2016 - 7:00AM
UK Regulatory
TIDMMDC
RNS Number : 9772Q
Mediclinic International PLC
05 December 2016
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
5 December 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
--------------------------------------------------------------------------------------------------------------------
1. Identity of the issuer or the underlying MEDICLINIC INTERNATIONAL PLC
issuer
of existing shares to which voting rights
are
attached:
-------------------------------------------------------------------- ----------------------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
--------------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------------------ ------------------------------------------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
------------------------------------------------------------------------ ------------------------------------------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
------------------------------------------------------------------------ ------------------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------------------ ------------------------------------------
Other (please
specify):
------------------------------------------------------------------- --- ------------------------------------------
3. Full name of person(s) subject PUBLIC INVESTMENT CORPORATION SOC LIMITED
to the
notification obligation:
-------------------------------------------------------------------- ----------------------------------------------
4. Full name of shareholder(s) N/A
(if different from 3.):
-------------------------------------------------------------------- ----------------------------------------------
5. Date of the transaction and date 01 December 2016
on
which the threshold is crossed
or
reached:
-------------------------------------------------------------------- ----------------------------------------------
6. Date on which issuer notified: 02 December 2016
-------------------------------------------------------------------- ----------------------------------------------
7. Threshold(s) that is/are crossed
or
reached: 8%
-------------------------------------------------------------------- ----------------------------------------------
8. Notified details:
-------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
-------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if
possible
using
the ISIN
CODE
----------- -------------------------------------------- --------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of shares rights
Shares Voting
Rights
----------- -------------------------- ---------------- ------------- -------------------- -------------------------
Direct Direct Indirect Direct Indirect
----------- --------- ----------- ------------ ------------- --------- --------- ------------ -----------
MEI
ORDINARY
SHARES 59 239 493 58 705 799 7.963%
-------------------------- ---------------- ------------- --------- --------- ------------ -----------
B: Qualifying Financial Instruments
-------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-------------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion Period rights that may rights
instrument be
acquired if the
instrument is
exercised/ converted.
--------------- ------------------------ ------------------------------- ---------------------- ---------------------
NONE N/A N/A N/A N/A
--------------- ------------------------ ------------------------------- ---------------------- ---------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments
-------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting rights
financial price date Conversion rights instrument
instrument period refers to
------------- ----------- --------------- -------------- ----------------------------------- -----------------------
Nominal Delta
------------- ----------- --------------- -------------- ----------------------------------- ------------ ---------
Total (A+B+C)
-------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
----------------------------------------------------------- ------------------------------------------------------------
58 705 799 7.963%
----------------------------------------------------------- ------------------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable:
-------------------------------------------------------------------------------------------
N/A
Proxy Voting:
-------------------------------------------------------------------------------------------
10. Name of the proxy holder: N/A
---------------------------------------------------------------------- -------------------
11. Number of voting rights proxy holder will N/A
cease
to hold:
---------------------------------------------------------------------- -------------------
12. Date on which proxy holder will cease to N/A
hold
voting rights:
---------------------------------------------------------------------- -------------------
13. Additional information: N/A
---------------------------------------------------------------------- -------------------
14. Contact name: DEVILLIERS MAKONKO
---------------------------------------------------------------------- -------------------
15. Contact telephone number: 012 742 3578
---------------------------------------------------------------------- -------------------
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH,
United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank
Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUVOARNKAURAA
(END) Dow Jones Newswires
December 05, 2016 07:00 ET (12:00 GMT)
Mediclinic (LSE:MDC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Mediclinic (LSE:MDC)
Historical Stock Chart
From Apr 2023 to Apr 2024
